JP2008046129A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008046129A5 JP2008046129A5 JP2007211829A JP2007211829A JP2008046129A5 JP 2008046129 A5 JP2008046129 A5 JP 2008046129A5 JP 2007211829 A JP2007211829 A JP 2007211829A JP 2007211829 A JP2007211829 A JP 2007211829A JP 2008046129 A5 JP2008046129 A5 JP 2008046129A5
- Authority
- JP
- Japan
- Prior art keywords
- amount
- cardiac troponin
- natriuretic peptide
- diagnosing
- measuring
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000004903 Troponin Human genes 0.000 claims 6
- 108090001027 Troponin Proteins 0.000 claims 6
- 230000000747 cardiac effect Effects 0.000 claims 6
- 108020001621 Natriuretic Peptide Proteins 0.000 claims 5
- 102000004571 Natriuretic peptide Human genes 0.000 claims 5
- 208000029078 coronary artery disease Diseases 0.000 claims 5
- 239000000692 natriuretic peptide Substances 0.000 claims 5
- 230000001154 acute effect Effects 0.000 claims 2
- 230000002526 effect on cardiovascular system Effects 0.000 claims 2
- 230000000750 progressive effect Effects 0.000 claims 2
- 102400001263 NT-proBNP Human genes 0.000 claims 1
- 102000013394 Troponin I Human genes 0.000 claims 1
- 108010065729 Troponin I Proteins 0.000 claims 1
- 102000004987 Troponin T Human genes 0.000 claims 1
- 108090001108 Troponin T Proteins 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 230000000302 ischemic effect Effects 0.000 claims 1
- 108010008064 pro-brain natriuretic peptide (1-76) Proteins 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06119017A EP1890153A1 (en) | 2006-08-16 | 2006-08-16 | Cardiac troponin as an indicator of advanced coronary artery disease |
| EP06119017.9 | 2006-08-16 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008046129A JP2008046129A (ja) | 2008-02-28 |
| JP2008046129A5 true JP2008046129A5 (enExample) | 2008-06-19 |
| JP4823170B2 JP4823170B2 (ja) | 2011-11-24 |
Family
ID=36968707
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007211829A Active JP4823170B2 (ja) | 2006-08-16 | 2007-08-15 | 進行型冠動脈疾患およびその合併症のインジケーターとしての心筋トロポニン |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US7927812B2 (enExample) |
| EP (1) | EP1890153A1 (enExample) |
| JP (1) | JP4823170B2 (enExample) |
| CN (1) | CN101126756A (enExample) |
| CA (1) | CA2597585A1 (enExample) |
| ES (1) | ES2390359T3 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008061978A2 (en) * | 2006-11-21 | 2008-05-29 | Roche Diagnostics Gmbh | Means and methods for optimization of diagnostic and therapeutic approaches in chronic artery disease based on the detection of troponin t and nt-probnp |
| EP1925943A1 (en) | 2006-11-21 | 2008-05-28 | F. Hoffman-la Roche AG | Means and methods for optimization of diagnostic and therapeutic approaches in chronic artery disease based on the detection of Troponin T and NT-proBNP. |
| WO2009141374A1 (en) * | 2008-05-21 | 2009-11-26 | F. Hoffmann-La Roche Ag | L-fabp, natriuretic peptides and cardiac troponin in individuals in need for a cardiac therapy |
| WO2009144229A1 (en) * | 2008-05-27 | 2009-12-03 | F. Hoffmann-La Roche Ag | Method for risk reduction in glycemic control |
| WO2009150249A1 (en) * | 2008-06-13 | 2009-12-17 | Roche Diagnostics Gmbh | Nt-probnp as prognostic indicator for the development of end stage renal disease in diabetes mellitus |
| EP2304438A1 (en) * | 2008-06-13 | 2011-04-06 | F. Hoffmann-La Roche AG | Assessment of complications of patients with type 1 diabetes |
| JP2012502290A (ja) * | 2008-09-11 | 2012-01-26 | エフ．ホフマン−ラ ロシュ アーゲー | メタボリックシンドロームを有する患者におけるナトリウム利尿ペプチドおよびアディポネクチン |
| WO2010042126A1 (en) * | 2008-10-11 | 2010-04-15 | Nanosphere, Inc. | Methods and assays to assess cardiac risk and ischemia |
| JP5678045B2 (ja) * | 2009-06-08 | 2015-02-25 | シンギュレックス・インコーポレイテッド | 高感度バイオマーカーパネル |
| EP2499489B1 (en) * | 2009-11-13 | 2015-01-07 | BG Medicine, Inc. | Risk factors and prediction of myocardial infarction |
| US8652788B2 (en) * | 2009-12-02 | 2014-02-18 | Abbott Laboratories | Assay for diagnosis of cardiac myocyte damage |
| EP3225994A1 (en) * | 2010-08-26 | 2017-10-04 | Roche Diagnostics GmbH | Use of biomarkers in the assessment of the early transition from arterial hypertension to heart failure |
| US20130236917A1 (en) * | 2010-11-12 | 2013-09-12 | The Johns Hopkins University | Albumin-bound protein/peptide complex as a biomarker for disease |
| EP2532748B1 (en) * | 2011-06-07 | 2014-10-08 | Postech Academy-industry Foundation | DNA aptamer specifically binding to human cardiac troponin I |
| EP4005582A1 (en) * | 2012-10-22 | 2022-06-01 | Stealth BioTherapeutics Inc. | Treatment of left ventricular remodeling |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5744101A (en) | 1989-06-07 | 1998-04-28 | Affymax Technologies N.V. | Photolabile nucleoside protecting groups |
| GB9211686D0 (en) | 1992-06-03 | 1992-07-15 | Medisinsk Innovation A S | Chemical compounds |
| US6520971B1 (en) | 2000-11-27 | 2003-02-18 | Scimed Life Systems, Inc. | Full thickness resection device control handle |
| US7632647B2 (en) * | 2001-04-13 | 2009-12-15 | Biosite Incorporated | Use of B-type natriuretic peptide as a prognostic indicator in acute coronary syndromes |
| EP1666881B1 (en) * | 2001-05-04 | 2010-02-17 | Biosite Incorporated | Diagnostic markers of acute coronary syndromes and methods of use thereof |
| US6461828B1 (en) * | 2001-09-04 | 2002-10-08 | Syn X Pharma | Conjunctive analysis of biological marker expression for diagnosing organ failure |
| MXPA03004105A (es) * | 2002-05-14 | 2004-10-15 | Hoffmann La Roche | Elaboracion de una prognosis en casos de enfermedad cardiaca usando una combinacion de marcadores. |
| US7074194B2 (en) * | 2003-05-19 | 2006-07-11 | Ischemia Technologies, Inc. | Apparatus and method for risk stratification of patients with chest pain of suspected cardiac origin |
| DE10351238A1 (de) | 2003-11-03 | 2005-06-02 | Roche Diagnostics Gmbh | Diagnosestellung von akuten myokardialen, ischämischen Erkrankungen durch Kombination von Markern |
-
2006
- 2006-08-16 EP EP06119017A patent/EP1890153A1/en not_active Withdrawn
-
2007
- 2007-08-10 ES ES07114174T patent/ES2390359T3/es active Active
- 2007-08-13 US US11/837,714 patent/US7927812B2/en active Active
- 2007-08-15 CA CA002597585A patent/CA2597585A1/en not_active Abandoned
- 2007-08-15 JP JP2007211829A patent/JP4823170B2/ja active Active
- 2007-08-16 CN CNA2007101421262A patent/CN101126756A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008046129A5 (enExample) | ||
| Mueller et al. | Inflammation and long-term mortality in acute congestive heart failure | |
| ATE373827T1 (de) | Kombination von markern für diabetes typ 1 und 2 | |
| DE602006014535D1 (de) | Verwendung von nt-proanp und nt-probnp zur diagnose von herzerkrankungen | |
| ATE403157T1 (de) | Verwendung des bnp-art und anp-art peptiden für das festsetzen der gefahren von herzgefäss- komplikationen als folge der volumenüberlastung | |
| Letsas et al. | Determinants of plasma NT-pro-BNP levels in patients with atrial fibrillation and preserved left ventricular ejection fraction | |
| DE602005001299D1 (de) | Kombinationen von Markern zum Nachweis von typ 1 und 2 Diabetes | |
| Koike et al. | Prognostic significance of cardiopulmonary exercise testing for 10-year survival in patients with mild to moderate heart failure | |
| JP2011528797A5 (enExample) | ||
| RU2012115125A (ru) | Мультимаркерная панель для гипертрофии левого желудочка | |
| Cozma et al. | Left atrial remodeling: assessment of size and shape to detect vulnerability to atrial fibrillation | |
| WO2004082639A3 (en) | Detecting coronary artery disease with bnp during stress testing | |
| Büyükavci et al. | Hypo-and hypervolemic edema in children with steroid sensitive nephrotic syndrome | |
| Kurpaska et al. | Multiparameter assessment of exercise capacity in patients with arterial hypertension | |
| Xi et al. | Red blood cell distribution width predicts responsiveness of acute pulmonary vasodilator testing in patients with idiopathic pulmonary arterial hypertension | |
| Boccalandro et al. | Relations among heart failure severity, left ventricular loading conditions, and repolarization length in advanced heart failure secondary to ischemic or idiopathic dilated cardiomyopathy | |
| JP2011511944A5 (enExample) | ||
| RU2005104714A (ru) | Способ ранней диагностики сердечной недостаточности при синдроме гипотиреоза | |
| Dudek et al. | Circulating N-terminal brain natriuretic peptide precursor and endothelin levels in patients with syndrome X and left bundle branch block with preserved systolic function | |
| RU2005112689A (ru) | Способ диагностики артериальной гипертензии, вызванной беременностью | |
| Tupper-Carey et al. | How silent is perioperative myocardial ischemia? A hemodynamic, electrocardiographic, and biochemical study in patients undergoing coronary artery bypass graft surgery | |
| JP2015503106A5 (enExample) | ||
| Abdul-Waheed et al. | Does left atrial volume affect exercise capacity of heart transplant recipients? | |
| RU2004134644A (ru) | Способ прогнозирования гнойно-воспалительных осложнений при лечении открытых переломов длинных трубчатых костей | |
| Huang et al. | Association of N-terminal pro brain natriuretic peptide and impaired aortic elastic property in hypertensive patients |